|
|
|
|
|
|
|
|
New platinum compound shows promise in tumor cells
"The new compound, mitaplatin, combines cisplatin with another compound, dichloroacetate (DCA), which can alter the properties of mitochondria selectively in cancer cells. Cancer cells switch their mitochondrial properties to change the way they metabolize glucose compared to normal cells, and DCA specifically targets the altered mitochondria, leaving normal cells intact."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.